Nano-D Drug Interactions

All drugs act different in each individual. The patient should check all the possible interactions of this medicine with any drug/food with their doctor before starting this medication.
Concomitant use of anticonvulsants (such as phenytoin) or barbiturates (and possibly other drugs that induce hepatic enzymes) may reduce the effect of Vitamin D3 by metabolic interactions.
In cases of treatment with thiazide diuretics, which decrease urinary elimination of calcium, monitoring of serum calcium concentration is recommended during treatment.
Concomitant use of glucocorticoids can decrease the effect of Vitamin D3.
In cases of treatment with drugs containing digitalis and other cardiac glycosides, administration of Vitamin D3 may increase the risk of digitalis toxicity (arrhythmia). Strict medical supervision is needed, together with serum calcium concentration and electrocardiographic monitoring.
Simultaneous treatment with ion exchange resin such as cholestyramine, colestipol hydrochloride, orlistat or laxative such as paraffin oil may reduce the gastrointestinal absorption of Vitamin D3.
The cytotoxic agent actinomycin and imidazole antifungal agents interfere with Vitamin D3 activity by inhibiting the conversion of 25-hydroxyvitamin D to 1, 25-dihydroxyvitamin D by the kidney enzyme, 25-hydroxyvitamin D-1-hydroxylase.
Interaction with Alcohol: Interaction with alcohol is unknown. It is advisable to consult the doctor before consumption.
Interaction with Medicine: Phenytoin, Aluminum Hydroxide/Magnesium Hydroxide, Calcitriol, Hydrochlorothiazide.
Disease Interactions: Disease: Information not available.
Food interactions: Information not available.
Lab interactions: Information not available.
This is not an exhaustive list of possible drug interactions. The patient should consult the doctor about all the possible interactions of the drugs the patient is taking.